Silicon Laboratories : Earnings Reports Q1 (e83bd214 8545 4a03 b223 52b440b60b5d)
SLAB
Published on 05/05/2026 at 04:07 pm EDT
April 4,
2026
April 5,
2025
Revenues
$ 213,500
$ 177,714
Cost of revenues
86,502
79,937
Gross profit
126,998
97,777
Operating expenses:
Research and development
88,594
88,219
Selling, general and administrative
55,486
41,638
Operating expenses
144,080
129,857
Operating loss
(17,082)
(32,080)
Other income (expense):
Interest income and other, net
3,626
3,793
Interest expense
(232)
(284)
Loss before income taxes
(13,688)
(28,571)
Provision for income taxes
2,209
1,899
Net loss
$ (15,897)
$ (30,470)
Loss per share: Basic
$ (0.48)
$ (0.94)
Diluted
$ (0.48)
$ (0.94)
Weighted-average common shares outstanding: Basic
32,963
32,465
Diluted
32,963
32,465
Current assets:
Cash and cash equivalents
$ 383,089
$ 364,222
Short-term investments
55,767
79,400
Accounts receivable, net
77,120
64,513
Inventories
103,232
95,566
Prepaid expenses and other current assets
57,113
70,316
Total current assets
676,321
674,017
Property and equipment, net
131,821
128,643
Goodwill
376,389
376,389
Other intangible assets, net
20,836
23,130
Other assets, net
61,094
67,138
Total assets $ 1,266,461 $ 1,269,317
Current liabilities:
Accounts payable
$ 56,384
$ 50,717
Deferred revenue and returns liability
9,822
5,359
Other current liabilities
66,273
87,711
Total current liabilities
132,479
143,787
Other non-current liabilities
35,448
31,112
Total liabilities
167,927
174,899
Commitments and contingencies
Stockholders' equity:
Preferred stock - $0.0001 par value; 10,000 shares authorized; no shares issued
-
-
Common stock - $0.0001 par value; 250,000 shares authorized; 32,968 and 32,955
shares issued and outstanding at April 4, 2026 and January 3, 2026, respectively
3
3
Additional paid-in capital
177,551
157,402
Retained earnings
920,917
936,814
Accumulated other comprehensive income
63
199
Total stockholders' equity
1,098,534
1,094,418
Total liabilities and stockholders' equity
$ 1,266,461
$ 1,269,317
April 4,
2026
April 5,
2025
Operating Activities
Net loss
$ (15,897)
$ (30,470)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation of property and equipment
6,047
6,248
Amortization of other intangible assets
2,295
5,437
Stock-based compensation expense
21,055
19,714
Deferred income taxes
1,153
(1,514)
Changes in operating assets and liabilities:
Accounts receivable
(12,608)
2,412
Inventories
(7,616)
22,098
Prepaid expenses and other assets
6,813
2,973
Accounts payable
3,387
9,234
Other current liabilities and income taxes
(7,415)
11,870
Deferred revenue and returns liability
4,463
3,405
Other non-current liabilities
3,257
(3,279)
Net cash provided by operating activities
4,934
48,128
Investing Activities
Purchases of marketable securities
-
(19,728)
Sales of marketable securities
-
10,005
Maturities of marketable securities
23,461
10,675
Purchases of property and equipment
(9,837)
(4,852)
Proceeds from capital-related government incentives
1,265
-
Net cash provided by (used in) investing activities
14,889
(3,900)
Financing Activities
Payment of taxes withheld for vested stock awards
(956)
(958)
Net cash used in financing activities
(956)
(958)
Increase in cash and cash equivalents
18,867
43,270
Cash and cash equivalents at beginning of period
364,222
281,607
Cash and cash equivalents at end of period
$ 383,089
$ 324,877
In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.
The non-GAAP financial measurements do not replace the presentation of Silicon Labs' GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs' financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core ongoing operations.
Non-GAAP Income Statement Items
GAAP
Measure
GAAP
Percent of Revenue
Stock Compensation Expense
Intangible Asset Amortization
Acquisition
-Related Costs
Other Costs
Non-GAAP
Measure
Non-GAAP
Percent of Revenue
enues $ 213,500
ss profit 126,998
59.5 %
$ 442
$ -
$ -
$ -
$ 127,440
59.7 %
earch and development 88,594
41.5 %
11,416
2,295
-
664
74,219
34.8 %
ing, general and
dministrative 55,486
26.0 %
9,197
-
11,213
-
35,076
16.4 %
rating expenses 144,080
67.5 %
20,613
2,295
11,213
664
109,295
51.2 %
rating income (loss) (17,082)
(8.0)%
21,055
2,295
11,213
664
18,145
8.5 %
Rev Gro Res
Sell a
Ope Ope
Income (loss) before
income taxes $ (13,688) $ 21,055 $ 2,295 $ 11,213 $ 664 $ - $ 21,539
Provision for income taxes 2,209 (16.1)% 1,668 3,877 18.0 %
Net income (loss) $ (15,897) $ 17,662
Diluted shares outstanding 32,963 585 33,548
Diluted earnings (loss) per
share $ (0.48) $ 0.53
Disclaimer
Silicon Laboratories Inc. published this content on May 05, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 05, 2026 at 20:06 UTC.